A Look at Pfizer's Valuation After FDA Approval of Next-Gen COVID Vaccine for Older Adults ...

Retrieved on: 2025-09-01 11:03:59

Tags for this article:

Research and development in the United States

Pfizer

COVID-19 vaccination in the United States

Seagen

BioNTech

PFIZER'S

Click the tags to see associated articles and topics

A Look at Pfizer's Valuation After FDA Approval of Next-Gen COVID Vaccine for Older Adults .... View article details on hiswai:

Excerpt

... BioNTech's updated COVID-19 vaccine for older adults and high-risk individuals. This move could breathe new life into Pfizer's vaccine revenues ...

Article found on: finance.yahoo.com

View Original Article